REAL-TIME GLOBAL RESEARCH
Lion (4912): 2Q results: Growth in value-added and mix improvement above expectations
Research evidence excerpt
J P M O R G A N
Asia Pacific Equity Research
08 August 2026
Lion (4912)
2Q results: Growth in value-added and mix
improvement above expectations
Somewhat positive: 2Q core operating profit of ¥9.3 billion was ¥800 million
above our ¥8.5 billion estimate. Lion made better progress than expected in raising
value-add and in improving the sales mix. Accelerating oral healthcare sales
growth (+4.1% YoY in 1Q, +10.5% in 1H) and an upturn in sales in China (–26%
in 1Q, +14.3% in 2Q) were also positive. Management expects raw material costs
to worsen because of the deteriorating situation in the Middle East, but left full-year
earnings guidance unchanged. We feel the visibility of FY2027 earnings growth
has also improved.
Overweight
4912.T, 4912 JP
Price (07 Aug 26):¥1,798
Price Target (Dec-26):¥2,150
Japan Equity Research
Cosmetics and Personal Care /
Paper and Packaging
Akiko Kuwahara AC
(81-3) 6736-8617
JPMorgan Securities Japan Co., Ltd.
Summary of company briefing on key points: (1) Steps to absorb worsening
raw material costs caused by the deteriorating Middle East situation: Lion’s 2H
raw material cost estimate has worsened by ¥5 billion from initial guidance,
breaking down as ¥3 billion in 3Q and ¥2 billion in 4Q. To absorb this, Lion
aims to boost gross profit by ¥4 billion (+¥1 billion from cost-cutting, +¥3
billion from price hikes) and to improve SG&A expenses by ¥1 billion as well.
It expects boosts from price hikes of ¥500 million in 3Q and ¥2.5 billion in 4Q.
(2) Impact of changed assumptions for 2H guidance on FY2027: Lion expects
raw material costs to worsen by a further ¥5 billion in 1H FY2027, as well, and
will need factors adding ¥10 billion to profit to achieve its medium-term core
operating profit target (¥40 billion in FY2027). 4Q FY2026 price hikes will
contribute over the full year, as well as a further ¥4–5 billion uplift to profits
from a better sales mix. It will also implement cost controls. (3) Background
to forecast for ¥200 million YoY decline in 2H impact from changes in sales
volumes: On top of the specialty chemicals business and the REED brand
divestments, the company expects sales volume declines due to product price
hikes.…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer